Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBaronsmead 2vt Regulatory News (BMD)

Share Price Information for Baronsmead 2vt (BMD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 56.50
Bid: 55.00
Ask: 58.00
Change: 0.00 (0.00%)
Spread: 3.00 (5.455%)
Open: 56.50
High: 56.50
Low: 56.50
Prev. Close: 56.50
BMD Live PriceLast checked at -
Baronsmead Second Venture Trust is an Investment Trust

To achieve long-term investment returns for private investors by investing primarily in a diverse portfolio of UK growth businesses, whether unquoted or traded on AIM.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of New Shares

20 Nov 2017 11:00

RNS Number : 9690W
Baronsmead Second Venture Trust PLC
20 November 2017
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR ANY JURISDICTION IN WHICH THE SAME COULD BE UNLAWFUL. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE AN OFFER OF SECURITIES FOR SALE IN ANY JURISDICTION, INCLUDING IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA.

BARONSMEAD SECOND VENTURE TRUST PLC

20 November 2017

Issue of New Shares pursuant to the Offer for Subscription

On 4 October 2017, Baronsmead Second Venture Trust plc (the "Company") published a prospectus (the "Prospectus") in relation to an offer for subscription to raise up to £24 million (the "Offer"). As announced by the Company on 8 November 2017, the Board of the Company resolved to move the date of the second allotment from 15 November 2017 to 17 November 2017.

The Company announced on 26 October 2017 that it had raised gross proceeds of approximately £13.5 million pursuant to the Offer and accordingly had issued 13,797,365 New Shares under the Offer. Since then the Company has raised additional gross proceeds of approximately £7.1 million. Accordingly the Company has carried out a second allotment of New Shares pursuant to the Offer, issuing 7,350,154 New Shares in aggregate at an issue price of 97.10 pence. The issue price of the second allotment has been calculated by dividing the Company's latest published Net Asset Value of 94.16 pence as at 31 October 2017 by 0.97 in accordance with the pricing formula set out in the Prospectus.

Applications have been made for the New Shares issued pursuant to the Offer to be admitted to the Official List (with a Premium Listing) and to the London Stock Exchange for the New Shares to be admitted to trading on the Main Market. It is expected that Admission will occur and dealing will commence in the New Shares to be issued pursuant to the Offer at 8.00 a.m. on 21 November 2017.

The Board announced on 8 November 2017 that the Offer had been extended and will remain open until 12 noon on 29 December 2017 or until such date as the Offer is fully subscribed or closed by the Directors, being no later than 29 December 2017. Following the second allotment the Company has raised gross proceeds of approximately £20.6 million pursuant to the Offer and there remains approximately £3.4 million of New Shares available for allotment.

It is expected that share certificates and tax certificates in respect of the New Shares will be issued to the relevant Shareholders on or around 27 November 2017.

Total voting rights

Each Ordinary Share has one voting right. Following the second allotment of New Shares pursuant to the Offer, the Company will have 230,185,440 Ordinary Shares in issue (of which 11,693,214 Ordinary Shares are held in treasury). The total number of voting rights in the Company will therefore be 218,492,226 and this figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure and Transparency Rules.

Definitions

Terms defined in the Prospectus have the same meanings in this announcement unless the context requires otherwise.

Further information

For further information please contact.

Michael Probin - VCT investor relations

Livingbridge VC LLP

020 7506 5796

Notes

This announcement does not constitute or form part of any offer to issue or sell, or any solicitation of any offer to subscribe or purchase, any investment in any jurisdiction, nor shall it (or the fact of its distribution) form the basis of, or be relied on in connection with, any contract therefor.

The issue and the distribution of this announcement and the Prospectus in certain jurisdictions may be restricted by law and persons into whose possession any document or other information referred to in this announcement and the Prospectus comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAEFEASFXFFF
Date   Source Headline
12th Aug 202211:44 amRNSIntention to Fundraise
4th Aug 20226:00 pmRNSNet Asset Value(s)
20th Jul 20227:00 amRNSNet Asset Value(s)
1st Jul 20223:44 pmRNSTotal Voting Rights
15th Jun 20227:00 amRNSTransaction in Own Shares
8th Jun 20223:15 pmRNSNet Asset Value(s)
27th May 20227:00 amRNSHalf-year Report
6th May 20223:15 pmRNSNet Asset Value(s)
3rd May 20225:12 pmRNSTotal Voting Rights
25th Apr 20225:28 pmRNSTransaction in Own Shares
19th Apr 20226:20 pmRNSDirector Declaration
14th Apr 20223:00 pmRNSNet Asset Value(s)
1st Apr 20227:00 amRNSTotal Voting Rights
15th Mar 20224:30 pmRNSIssue of Ordinary Shares
15th Mar 202211:05 amRNSDirector/PDMR Shareholding
11th Mar 20223:00 pmRNSNet Asset Value(s)
9th Mar 20227:00 amRNSTransaction in Own Shares - Correction
8th Mar 20223:53 pmRNSTransaction in Own Shares
7th Mar 20223:31 pmRNSPublication of a Prospectus
3rd Mar 20221:30 pmRNSNet Asset Value(s)
1st Mar 202211:47 amRNSTotal Voting Rights
28th Feb 20224:51 pmRNSOffer for Subscription - Update
16th Feb 20224:51 pmRNSResult of AGM
4th Feb 20225:45 pmRNSNet Asset Value(s)
3rd Feb 20224:57 pmRNSTotal Voting Rights
1st Feb 20222:53 pmRNSTotal Voting Rights
28th Jan 202211:58 amRNSAllotment of Shares
27th Jan 20223:30 pmRNSNet Asset Value(s)
26th Jan 20224:59 pmRNSTransaction in Own Shares
21st Jan 20222:00 pmRNSNet Asset Value(s)
4th Jan 20221:34 pmRNSTotal Voting Rights
22nd Dec 20214:51 pmRNSAllotment of Shares
20th Dec 20216:18 pmRNSTransaction in Own Shares
20th Dec 202112:37 pmRNSUpdate on Fundraising
8th Dec 20215:08 pmRNSCorrection: Annual Financial Report
8th Dec 202112:19 pmRNSDirector/PDMR Shareholding
8th Dec 202111:54 amRNSDirector/PDMR Shareholding
8th Dec 202111:53 amRNSDirector/PDMR Shareholding
8th Dec 202111:52 amRNSDirector/PDMR Shareholding
7th Dec 20214:04 pmRNSPublication of a supplementary prospectus
6th Dec 20215:20 pmRNSAllotment of Shares
6th Dec 202112:24 pmRNSAnnual Financial Report
3rd Dec 20214:00 pmRNSNet Asset Value(s)
10th Nov 20218:00 amRNSOffer Update - Extension of Earlybird Rebate
8th Nov 20215:45 pmRNSNet Asset Value(s)
4th Nov 20211:00 pmRNSPublication of a Prospectus
28th Oct 20213:00 pmRNSReplacement Net Asset Value(s)
21st Oct 20211:00 pmRNSNet Asset Value(s)
1st Oct 202111:36 amRNSTotal Voting Rights
29th Sep 20216:28 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.